707 Cayman has signed a term sheet to acquire a pharmaceutical company. The deal remains subject to further due diligence and final agreements.
Further details about the target company or financial terms were not immediately available.

The investment firm has entered into a preliminary agreement to purchase a pharmaceutical company.

707 Cayman has signed a term sheet to acquire a pharmaceutical company. The deal remains subject to further due diligence and final agreements.
Further details about the target company or financial terms were not immediately available.

Lucas covers M&A activity and startup funding rounds, tracking deal structures and valuations to explain what a transaction means for the companies and markets involved.
More from Lucas Ferreira →

